Publications by authors named "P Sfumato"

Claim this Profile
L
Long-Term Outcomes and Management Strategies With DA-R-EPOCH in Primary Mediastinal B-Cell Lymphoma: Insights From a Single-Center Experience.
Robin Noel, Catalina Montes de Oca, Patrick Sfumato, Anne Calleja, Aude Collignon

Hematol Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Group sequential methods based on supremum logrank statistics under proportional and nonproportional hazards.
Jean Marie Boher, Thomas Filleron, Patrick Sfumato, Pierre Bunouf, Richard J Cook

Stat Methods Med Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials.
Claire L Vale, David J Fisher, Peter J Godolphin, Larysa H Rydzewska, Jean-Marie Boher, Patrick Sfumato

Lancet Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Musculoskeletal immune-related adverse events in 927 patients treated with immune checkpoint inhibitors for solid cancer.
Angélique Melia, Emilie Fockens, Patrick Sfumato, Christophe Zemmour, Anne Madroszyk

Joint Bone Spine· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A stratified adaptive two-stage design with co-primary endpoints for phase II clinical oncology trials.
Bastien Cabarrou, Eve Leconte, Patrick Sfumato, Jean-Marie Boher, Thomas Filleron

BMC Med Res Methodol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis